Reuters logo
BRIEF-Neos Therapeutics receives U.S. FDA approval
September 15, 2017 / 9:31 PM / 10 days ago

BRIEF-Neos Therapeutics receives U.S. FDA approval

Sept 15 (Reuters) - Neos Therapeutics Inc

* Neos Therapeutics receives U.S. FDA approval of Adzenys ER™ (amphetamine) extended-release oral suspension for the treatment of ADHD in patients 6 years and older

* Neos Therapeutics Inc - ‍look forward to commercial launch of Adzenys ER in early 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below